[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "A sad day", "description": "Excess deaths, non covid\n\nOur world in data\nhttps://ourworldindata.org/grapher/excess-mortality-p-scores-average-baseline?country=CAN~AUS~IRL~USA~GBR~NZL~NLD~ITA\n\nhttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights#deaths\n\nCovid in decline\n\nE.g. US, 14 day change\n\nCases, down 21%\n\nHospitalized, down 13%\n\nDeaths, down 13%\n\nExcess deaths\n\nWeek ending 26 August 2022\n\nRegistered COVID-19 deaths \n= 505\n\nDecrease from 622 last week\n\nTotal number of deaths registered in the UK\n\n12,330\n\n15.4% above the five-year average\n\n(1,646 excess deaths for the week)\n\nCovid deaths, 4.1% of all deaths\n\nAustralia\nhttps://www1.racgp.org.au/newsgp/clinical/why-are-more-people-dying-in-australia-many-questi\n\nExcess deaths for 2022\n\n16.6%\n\nhttps://app.powerbi.com/view?r=eyJrIjoiYmUwNmFhMjYtNGZhYS00NDk2LWFlMTAtOTg0OGNhNmFiNGM0IiwidCI6ImVlNGUxNDk5LTRhMzUtNGIyZS1hZDQ3LTVmM2NmOWRlODY2NiIsImMiOjh9\n\nLast 19 weeks, English data\n\nExcess deaths is in all age groups\n\n0 to 24 years\n25 to 49 years\n50 to 64 years\n\nExcess deaths from specific causes\n\nIschaemic heart disease\nHeart failure\nCancer\nAcute respiratory\nChronic respiratory\nDiabetes\nUrinary, Liver and cirrhosis, Parkinsons\n\nProximal versus distal causes\n\nDistal causes\n\nHealth care access issues\n\nWaiting lists for treatment\n\nFear from attending during lockdowns\n\nTelephone triage\n\nReview of long-term treatments\n\nDelayed diagnosis\n\nLong covid\n\nPost covid syndromes\n\n(Covid sequelae)\n\nLock down sequelae\n\nPhysical\n\nPsychogenic\n\nhttps://support.google.com/youtube/answer/11161123\n\nhttps://support.google.com/youtube/answer/9891785", "link": "https://www.youtube.com/watch?v=4WZHtxGF4Cc", "date_published": "2022-09-08 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "FDA approves BA. 5 vaccine", "description": "U.S. Food and Drug Administration, amended the emergency use authorizations (EUAs),\n\nhttps://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-pfizer-biontech-bivalent-covid-19-vaccines-use\n\nof the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine\n\nto authorize bivalent formulations\n\nBA.4 and BA.5 lineages of the omicron variant of SARS-CoV-2. \n\nOmicron booster shots, with lots of questions\n\n https://www.science.org/content/article/omicron-booster-shots-are-coming-lots-questions\n\nUnited Kingdom has authorized Moderna Omicron subvariant BA.1\n\nModerna and Pfizer-BioNTech, have submitted data about their BA.4/BA.5 vaccines \n\nBiden administration\n\nHas already placed an order for 170 million doses\n\nWhat do the new boosters contain?\n\nMessenger RNA (mRNA) coding for the spike protein of SARS-CoV-2\n\nBivalent, Wuhan strain and BA.1 or BA.4 and BA.5 (which have identical spikes)\n\nWhat sort of data have the companies collected?\n\nHuman data, only available BA.1 booster\n\nBA.1 trails did not look for protection against severe disease, (People trials are very expensive)\n\nFor the BA.4/BA.5 boosters, the companies have submitted animal data. \n\n(not released publicly)\n\nPfizer presented preliminary findings in eight mice given BA.4/BA.5 vaccines as their third dose, (for EMA)\n\nShowed an increased antibody response to all Omicron variants tested: BA.1, BA.2, BA.2.12.1, BA.4, and BA.5.\n\nClinical trials for the BA.4/BA.5 vaccines will begin next month\n\nWhy still target the ancestral strain?\n\nProbably for new variants, more polyclonal response\n\nStill has some neutralising power against the new variants\n\nIf the benefits are limited, do we really need the new boosters?\n\nSome scientists don\u2019t think we do. \n\nPaul Offit, vaccine researcher, Children\u2019s Hospital of Philadelphia\n\nCOVID-19 vaccines still prevent the most severe outcomes\n\nIf the goal is to stop infections, even updated vaccines will have little impact\n\n(Incubation period is too short)\n\n(Measles or rubella, 2-week incubation period, so can stop spread)\n\neven if 100% of the population were vaccinated,\n\nand the virus hadn\u2019t evolved at all, \n\nvaccines would do very little to stop transmission\n\nhttps://support.google.com/youtube/answer/11161123\n\nEfficacy of vaccines: content claiming that vaccines do not reduce transmission or contraction of disease \n\nhttps://support.google.com/youtube/answer/9891785\n\nClaims that any medication or vaccination is a guaranteed prevention method for COVID-19\n\nThe Biopharmaceutical Industry Provides 75% Of The FDA's Drug Review Budget. Is This A Problem?\n\nhttps://www.forbes.com/sites/johnlamattina/2018/06/28/the-biopharmaceutical-industry-provides-75-of-the-fdas-drug-review-budget-is-this-a-problem/?sh=7bf0d65049ec\n\nCaroline Chen\n\nthe agency is beholden to the biopharmaceutical industry\n\nGiven this level of support, one might assume that the FDA would bend over backwards to meet the needs of its financial backers.\n\nCaroline Chen ProPublica\n\nhttps://www.propublica.org/article/fda-repays-industry-by-rushing-risky-drugs-to-market\n\nDr. Thomas Marciniak\n\n(former FDA medical team leader)\n\nYou don\u2019t survive as a senior official at the FDA unless you\u2019re pro-industry\n\nThe FDA has to pay attention to what Congress tells them to do, and the industry will lobby to get somebody else in there if they don\u2019t like you\n\nPfizer\n\nhttps://www.theguardian.com/business/2022/may/03/pfizer-covid-sales-pricing-vaccine-paxlovid-pill\n\nhas made nearly $26bn (\u00a321bn) in revenues in the first three months of the year\n\nCovid-19 vaccines and treatments\n\nExpects record sales of $98bn to $102bn this year, \n\nhalf of which will come from Covid products, Comirnaty and Paxlovid\n\nprompting fresh accusations of pandemic profiteering.\n\nAstraZeneca, Chief executive officer, Pascal Soriot\n\nhttps://www.independent.co.uk/news/uk/astrazeneca-people-medicines-and-healthcare-products-regulatory-agency-office-for-national-statistics-uk-government-b2154286.html\n\n(27th August)\n\nMost of the vaccinated population has a foundation immunity against severe disease\n\nPeople who are otherwise healthy \u2013 especially if they are young, have been vaccinated, have had a boost already \u2013 boosting them again, \n\nI\u2019m just not sure it\u2019s really a good use of resources.\n\nFoundation immunity lasts, a long time, we don\u2019t know if it\u2019s one year, two years, three years. \n\nI think more than one year for sure\n\nOn boosting people every year\n\nI\u2019m not sure it\u2019s a really good use of money, \n\nbecause most of the people now who catch it will just have symptoms if they get Covid, and that\u2019s it", "link": "https://www.youtube.com/watch?v=i4q0ZvfcWDk", "date_published": "2022-09-07 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]